Ascletis Pharma Market Cap

Ascletis Pharma has a market cap or net worth of 12.3 billion as of January 13, 2026. Its market cap has increased by 434.68% in one year.

Market Cap

12.30B

Enterprise Value

10.33B

Revenue

2.59M

Ranking

n/a

PE Ratio

n/a

Stock Price

12.87

Market Cap Chart

Since August 1, 2018, Ascletis Pharma's market cap has decreased from 15.69B to 12.30B, a decrease of -21.63%. That is a compound annual growth rate of -3.22%.

Market Cap History

Date	Market Cap	% Change
Jan 12, 2026	12.30B	9.39%
Dec 31, 2025	11.24B	287.10%
Dec 31, 2024	2.90B	90.74%
Dec 29, 2023	1.52B	-70.46%
Dec 30, 2022	5.15B	44.13%
Dec 31, 2021	3.58B	13.38%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Aug 1, 2018	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BeOne Medicines AG	291.47B
Hansoh Pharmaceutical Group Company	251.84B
JD Health International	204.91B
Innovent Biologics	153.67B
WuXi Biologics	152.99B
Sino Biopharmaceutical	122.10B
Akeso	117.54B
Sichuan Kelun-Biotech Biopharmaceutical	111.09B

Market Cap Rankings